New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

Cancer Center's Ties Raise Concerns December 6, 2018
Express Scripts' New Formulary Includes Lower List Prices November 14, 2018
Cigna, Express Scripts Announce Program to Cap Insulin Costs April 3, 2019
Efforts to Bolster PROs Expected to Play Key Role in Cancer… February 12, 2019
Bach Takes Aim at Zolgensma Pricing June 18, 2019
eDossier System to Offer hēRo3 Model Integration November 8, 2018
More on New CVS Health Pricing Model December 6, 2018